Dermatologic Therapy is a leading peer-reviewed journal published by WILEY-HINDAWI that focuses on the multifaceted field of dermatology. Established in 1996 and continuing its profound impact into 2024, the journal has earned an impressive Q1 rating in Dermatology and ranks 11th out of 142 in the Scopus categorization, placing it in the 92nd percentile. With its headquarters in the United Kingdom, the journal's mission is to advance the understanding and treatment of skin diseases through the dissemination of high-quality research, reviews, and clinical information. Although not an open-access journal, it provides extensive access options to ensure that vital research reaches its audience. By leading scholarly discourse and innovation in dermatological treatments, Dermatologic Therapy serves as an essential resource for researchers, clinicians, and students dedicated to improving skin health worldwide.

The Indian Journal of Dermatology Venereology & Leprology (IJDL) is a premier open-access journal dedicated to the fields of dermatology, venereology, and leprology, published by SCIENTIFIC SCHOLAR LLC since 2004. With a rich historical background dating back to 1976, the journal has established itself as a reputable source for high-quality research and clinical advancements in these disciplines. The IJDL is recognized for its academic rigor, boasting a 2023 category quartile ranking of Q2 in Dermatology and Q3 in Infectious Diseases, indicating its significant contribution to these fields. With an accessible online platform, researchers, practitioners, and students alike can readily explore the latest studies, case reports, and reviews that address key issues affecting public health, particularly in India and beyond. The journal serves not only as a repository of valuable knowledge but also as a vital forum for the exchange of ideas, fostering collaboration and innovation among professionals dedicated to enhancing skin health and combating infectious diseases.

EXPERIMENTAL DERMATOLOGY, published by WILEY, is a leading journal in the fields of Biochemistry and Dermatology, with impressive rankings including Q1 status in both categories as of 2023. With its ISSN 0906-6705 and E-ISSN 1600-0625, the journal offers a reputable platform for disseminating cutting-edge research and insights into skin biology and related health issues. As a pivotal resource for professionals, researchers, and students alike, EXPERIMENTAL DERMATOLOGY includes a broad scope of topics, fostering a deeper understanding of dermatological conditions and enhancing new therapeutic strategies. The journal’s distinguished performance is highlighted by its Scopus rankings, which place it at the 91st percentile in Medicine-Dermatology and the 65th in Biochemistry. While not an open-access publication, the journal remains committed to ensuring the accessibility of crucial developments within the dermatological community worldwide, facilitating the advancement of both clinical practice and academic inquiry.

World Allergy Organization Journal is a premier open-access publication dedicated to advancing the understanding and treatment of allergic diseases and related conditions. Published by ELSEVIER, this journal boasts a commendable impact factor and ranks in the second quartile for both Immunology and Allergy, as well as the first quartile in Pulmonary and Respiratory Medicine. Since its inception as an open-access journal in 2008, it has consistently aimed to provide a credible platform for researchers, clinicians, and students to disseminate original research, reviews, and clinical studies. With its emphasis on high-quality scholarship and practical applications, the World Allergy Organization Journal plays a crucial role in bridging theoretical knowledge with clinical practice, making significant contributions to the fields of immunology, allergy, and respiratory medicine. The journal is particularly notable for its accessibility to a global audience, exemplified by its open-access model since 2008, promoting a wider exchange of ideas and innovations across borders.

JOURNAL OF INVESTIGATIVE DERMATOLOGY, published by Elsevier Science Inc, stands at the forefront of research in the fields of dermatology, biochemistry, cell biology, and molecular biology. With an impressive impact factor reflecting its Q1 ranking in Dermatology and Biochemistry, this journal provides a vital platform for disseminating groundbreaking research and innovative studies that drive forward our understanding of skin biology and disease. The journal has maintained a distinguished presence since its inception in 1945, successfully converging decades of scientific inquiry and expertise. It ranks among the top journals in medicine and dermatology, holding a remarkable 7th place out of 142 in the Scopus Medicine Dermatology category, signaling its influence and relevance in the academic community. Researchers, professionals, and students alike will find valuable insights into cutting-edge investigations and methodologies to advance their own studies in skin health and pathology. While the journal is not an open access publication, access options remain robust for institutions and individuals committed to the advancement of dermatological science.

The British Journal of Dermatology, published by Oxford University Press, stands as a premier platform for advancing the field of dermatological research and clinical practice since its inception in 1892. With a strong commitment to disseminating high-quality research, this esteemed journal is currently ranked in the Q1 category for both Dermatology and Miscellaneous Medicine in 2023, reflecting its influential position in the academic landscape. As the leading journal in its field, it enjoys a robust Scopus ranking of #1 out of 142 in dermatology, placing it in the 99th percentile globally. The journal covers a wide scope of subjects pertinent to dermatology, including clinical trials, treatment innovations, and epidemiological studies, making it an essential resource for researchers, healthcare professionals, and students alike. Although it is not an open-access publication, it ensures a broad reach through institutional subscriptions, fostering knowledge exchange across the global dermatological community. Based in the heart of the United Kingdom, the British Journal of Dermatology continues to play a crucial role in shaping the future of skin health and disease management.

Veterinary Dermatology is a prestigious peer-reviewed journal dedicated to advancing the field of veterinary dermatology, published by Wiley. With a longstanding commitment to disseminating high-quality research since its inception in 1990, this journal has garnered significant recognition, achieving a commendable Q1 ranking in the Veterinary (miscellaneous) category for 2023 and ranking #42 out of 194 in the General Veterinary category on Scopus, placing it within the 78th percentile. Although it operates primarily on a subscription basis, the journal offers vital insights into the latest developments, clinical practices, and case studies in veterinary skin disorders. By serving as a crucial platform for researchers, veterinary professionals, and students, Veterinary Dermatology empowers its audience with the knowledge necessary to enhance animal healthcare and well-being across diverse environments. With its focus on cutting-edge research and its contribution to the global veterinary community, this journal remains an indispensable resource for those dedicated to the field.

Dermatitis, published by MARY ANN LIEBERT, INC, is a leading journal that focuses on the study of skin inflammation and allergic reactions, making significant contributions to the fields of Dermatology, Immunology, and Allergy. With an ISSN of 1710-3568 and an E-ISSN of 2162-5220, this peer-reviewed journal serves as a critical platform for researchers, healthcare professionals, and students alike, eager to share and explore groundbreaking findings and developments. Recognized for its impact and rigorous scholarly standards, Dermatitis has achieved a Q2 quartile ranking in dermatology and a Q3 ranking in immunology and allergy as of 2023, underscoring its significance in these vital medical sectors. The journal's Scopus ranking places it in the 84th percentile for dermatology and the 50th percentile for immunology and allergy, reflecting its wide acceptance and influence. With a scope spanning from 2004 to 2024, Dermatitis invites original research, reviews, and clinical updates that advance the understanding of skin disorders and therapy innovations, solidifying its role as an essential resource in enhancing skin health worldwide.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, published by Wiley, is a prominent periodical in the field of dermatology, recognized by its Q2 quartile ranking in the 2023 dermatology category. With a dedicated focus on advancing knowledge in dermatological science, the journal publishes rigorous peer-reviewed research that encompasses a range of topics including clinical studies, research methodologies, and innovative treatment practices in dermatology. Its impact is reflected in its Scopus ranking, where it stands at #48 out of 142 in the medicine dermatology category, placing it in the top 66th percentile. Although not an Open Access journal, it serves as a critical resource for researchers, clinicians, and students alike, facilitating the dissemination of high-quality research findings and fostering a deeper understanding of dermatological conditions and treatments. With years of convergence from 2003 to 2024, this journal remains a vital platform for scholarly dialogue and discovery in dermatology.

Acta Dermatovenerologica Croatica is a premier journal dedicated to the fields of dermatology and venereology, published by the Croatian Dermatovenereological Society. Established in 1994, this journal has been a vital platform for disseminating research and advancements in the understanding and treatment of skin diseases and sexually transmitted infections. Although it is currently classified in the Q4 quartile for dermatology, infectious diseases, and miscellaneous medicine, it provides a unique opportunity for emerging researchers and seasoned professionals to contribute to a growing body of knowledge. Based in Zagreb, Croatia, the journal emphasizes free access to information that enhances clinical practices and scientific understanding among dermatologists and venereologists worldwide. As the journal approaches its 30th anniversary, it continues to aim for excellence in research quality, fostering collaboration, and innovating in the ever-evolving fields it represents.